# Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population

> **NCT03742271** · NA · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 130 (actual)

## Conditions studied

- Visual Acuity

## Interventions

- **DEVICE:** senofilcon A

## Key facts

- **NCT ID:** NCT03742271
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742271, "Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03742271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*